Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 60, Issue 3, Pages 931-940
Publisher
Wiley
Online
2014-02-12
DOI
10.1002/hep.27074
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus
- (2013) N Phan et al. ACTA DERMATO-VENEREOLOGICA
- Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids
- (2013) Justine H. Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate
- (2013) J Trottier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Primary sclerosing cholangitis
- (2013) Gideon M Hirschfield et al. LANCET
- Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
- (2012) Karin Dilger et al. JOURNAL OF HEPATOLOGY
- Improvement of serum alkaline phosphatase to
- (2012) Said Al Mamari et al. JOURNAL OF HEPATOLOGY
- Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to Fenofibrate
- (2011) J Trottier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study
- (2011) Jocelyn Trottier et al. DIGESTIVE AND LIVER DISEASE
- Liver transplantation in chronic cholestatic conditions
- (2011) Piotr Milkiewicz Frontiers in Bioscience-Landmark
- FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways
- (2011) Ai-Luen Wu et al. PLoS One
- Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting
- (2011) Jocelyn Trottier et al. PLoS One
- Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression
- (2010) Emmanouil Sinakos et al. HEPATOLOGY
- High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: Throwing the urso out with the bathwater?
- (2009) Roger W. Chapman HEPATOLOGY
- Diagnosis and management of primary sclerosing cholangitis
- (2009) Roger Chapman et al. HEPATOLOGY
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- Primary biliary cirrhosis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
- (2009) Yazen Alnouti TOXICOLOGICAL SCIENCES
- High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis
- (2008) Frank G. Schaap et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now